Vol 10, No 4 (2014)

Date published: 2014-08-29

Table of Contents

open access


Monoclonal antibodies in medical oncology — mechanism of action

Piotr J. Wysocki

Review paper

Onkol. Prak. Klin 2014;10(4):175-183.

EGFR tyrosine kinase inhibitors in the first-line or second-line treatment of patients with EGFR gene activating mutation

Magdalena Knetki-Wróblewska, Adam Płużański, Maciej Krzakowski

Review paper

Onkol. Prak. Klin 2014;10(4):184-191.

Molecular determinants of lung cancer

Magdalena Potempa, Paweł Jonczyk, Marzena Zalewska-Ziob

Review paper

Onkol. Prak. Klin 2014;10(4):199-211.

Colorectal cancer — the social significance of changes in the epidemiology and treatment options in Poland

Rafał Zyśk, Piotr Wysocki, Lucjan Wyrwicz

Review paper

Onkol. Prak. Klin 2014;10(4):212-223.
Onkologia na świecie

Advances in the surgical management of bone tumors

Justin E. Bird

Other materials agreed with the Editors

Onkol. Prak. Klin 2014;10(4):224-230.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl